Target intelligence / Profile preview

Organic cation transporter family protein (OCT (for "Organic cation transporter"); specific members include OCT1, OCT2, and OCT3)

Target
OCT (for "Organic cation transporter"); specific members include OCT1, OCT2, and OCT3
Molecular classification
Transporter, Solute carrier (SLC) superfamily, SLC22 family
01

Overview

The organic cation transporter family proteins are membrane-bound proteins primarily responsible for the uptake and secretion of a wide range of endogenous organic cations—including monoamine neurotransmitters—and numerous therapeutic drugs. They belong mainly to the solute carrier 22 (SLC22) gene family. These transporters are highly expressed in organs involved in detoxification and excretion such as the kidney and liver but are also found in other tissues like brain and intestine. Their ability to recognize structurally diverse compounds makes them key determinants in pharmacokinetics—affecting how drugs are absorbed, distributed, metabolized, and eliminated from the body. Variability among individuals—due either to genetic differences or interactions with other substances—can significantly impact clinical outcomes by altering exposure levels for various medications. The clinical importance is underscored by their role both as direct therapeutic targets themselves and as mediators/modifiers of response/toxicity profiles for many commonly used pharmaceuticals.

Other names
Organic cation transporterSLC22 family proteinPolyspecific organic cation transporterSolute carrier family 22 member (e.g., SLC22A1 for OCT1)Organic cation/carnitine/zwitterion transporters (OCTN)
02

Mechanism of action

Drugs interact by being transported across cell membranes via facilitated diffusion or exchange mechanisms; inhibition or genetic variation can alter drug absorption/elimination leading to changes in efficacy or toxicity

03

Biological functions

Transport of endogenous organic cations such as monoamine neurotransmitters, choline, and coenzymesUptake and secretion of drugs and xenobioticsRegulation of drug bioavailability and pharmacokineticsHomeostasis of organic ions in tissues including kidney, liver, brain, placenta, intestine, lung
04

Disease associations

Cancer (due to altered drug disposition)Cardiovascular disease (via effects on neurotransmitter levels)Neurodegenerative disease (by modulating neurotransmitter availability)Other diseases related to impaired drug clearance or toxicity
05

Safety considerations

Notable safety concerns include potential for significant drug–drug interactions due to the broad substrate specificitygenetic polymorphisms may lead to variable patient responsesmutations can cause impaired excretion leading to toxicity or reduced efficacy of medications
06

Interacting drugs

Common substrates include a broad spectrum of therapeutic drugs such as metformin, cisplatin, procainamide; also interacts with many other drugs due to polyspecificity
07

Biomarkers

Polymorphisms in genes encoding these transporters can serve as biomarkers for predicting individual responses to certain medications or risk for adverse effects due to altered transport activity

Beyond the preview

Go deeper on Organic cation transporter family protein (OCT (for "Organic cation transporter"); specific members include OCT1, OCT2, and OCT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Organic cation transporter family protein (OCT (for "Organic cation transporter"); specific members include OCT1, OCT2, and OCT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call